SEC Form 4 · accession 0000899866-15-000117
ALEXION PHARMACEUTICALS, INC. · ALXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Leonard Bell
Director
Period of report
May 6, 2015
Accepted (ET)
May 8, 2015 · 6:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899866
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per shareF1 | May 6, 2015 | A | 700 | $0.00 | A | 950,126 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF2 | $155.01 | May 6, 2015 | A | 2,343 | A | May 6, 2016 | May 6, 2025 | Common Stock, par value $.0001 per share | 2,343 | 2,343 | D |
Explanation of responses
- F1Annual award of restricted stock units under 2004 Incentive Plan. 100% vests on the first anniversary of the grant date.
- F2Annual award of stock options under 2004 Incentive Plan. 100% vests on the first anniversary of the grant date.